The estimated Net Worth of Holly R Sheffield is at least $3.11 Milion dollars as of 8 January 2024. Ms. Sheffield owns over 986 units of Cooper Companies stock worth over $603,750 and over the last 6 years she sold COO stock worth over $0. In addition, she makes $2,505,570 as President - CooperSurgical at Cooper Companies.
Holly has made over 11 trades of the Cooper Companies stock since 2020, according to the Form 4 filled with the SEC. Most recently she exercised 986 units of COO stock worth $106,991 on 8 January 2024.
The largest trade she's ever made was exercising 1,105 units of Cooper Companies stock on 4 June 2022 worth over $119,904. On average, Holly trades about 561 units every 86 days since 2018. As of 8 January 2024 she still owns at least 5,564 units of Cooper Companies stock.
You can see the complete history of Ms. Sheffield stock trades at the bottom of the page.
Holly R. Sheffield has been appointed as President - CooperSurgical of the Company effective 7/13/2020. Prior to joining Cooper, Ms. Sheffield had over 20 years of experience in investment banking. She joined Cooper from UBS Securities LLC, where she was a Managing Director, Global Head of Medical Technology from 2009 to May 2018. From 2000 to 2009, Ms. Sheffield was at Credit Suisse and from 1997-2000, Ms. Sheffield was at Donaldson, Lufkin & Jenrette until it was acquired by Credit Suisse. Ms. Sheffield received a B.S. from Cornell University and an M.B.A. from Columbia Business School.
As the President - CooperSurgical of Cooper Companies, the total compensation of Holly Sheffield at Cooper Companies is $2,505,570. There are 2 executives at Cooper Companies getting paid more, with Albert White having the highest compensation of $7,724,740.
Holly Sheffield is 49, she's been the President - CooperSurgical of Cooper Companies since 2020. There are 16 older and 3 younger executives at Cooper Companies. The oldest executive at Cooper Companies, Inc. is A. Thomas Bender, 80, who is the Independent Chairman of the Board.
Holly's mailing address filed with the SEC is C/O THE COOPER COMPANIES, INC., 6101 BOLLINGER CANYON ROAD, SUITE 500, SAN RAMON, CA, 94583.
Over the last 21 years, insiders at Cooper Companies have traded over $45,273,696 worth of Cooper Companies stock and bought 5,157 units worth $1,262,486 . The most active insiders traders include Robert S Weiss, William A Kozy a Lawrence Erik Kurzius. On average, Cooper Companies executives and independent directors trade stock every 18 days with the average trade being worth of $1,325,775. The most recent stock trade was executed by Brian G Andrews on 5 September 2024, trading 24,788 units of COO stock currently worth $939,713.
company overview the cooper companies, inc. ("cooper") is a global medical device company publicly traded on the nyse euronext (nyse:coo). cooper is dedicated to being a quality of life company™ with a focus on delivering shareholder value. cooper operates through two business units, coopervision and coopersurgical. coopervision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. coopersurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. headquartered in pleasanton, ca, cooper has approximately 9,000 employees with products sold in over 100 countries. for more information, please visit www.coopercos.com.
Cooper Companies executives and other stock owners filed with the SEC include: